Hemas Holdings PLC (HHL) and its subsidiaries achieved consolidated revenues of Rs. 28.3 billion, year-on-year (YoY) growth of 19.7 per cent for the nine months ended December 31, 2005 with operating profit reaching Rs. 2.8 per cent and earnings Rs. 1.9 billion, growth of 25.6 per cent and 65.2 per cent, respectively.  Eliminating the one [...]

The Sunday Times Sri Lanka

Hemas earnings Rs. 1.9 bln for 1-3QFY16

View(s):

Hemas Holdings PLC (HHL) and its subsidiaries achieved consolidated revenues of Rs. 28.3 billion, year-on-year (YoY) growth of 19.7 per cent for the nine months ended December 31, 2005 with operating profit reaching Rs. 2.8 per cent and earnings Rs. 1.9 billion, growth of 25.6 per cent and 65.2 per cent, respectively.  Eliminating the one off transactions in the preceding year and the additional interest income of Rs. 196 million earned from investing the proceeds of the rights issue, underlying operating profit and earnings maintained a growth of 30.8 per cent and 30.2 per cent respectively, a media release by the company said.

The FMCG sector achieved total revenues of Rs 11.2 billion for the nine months, a 24.4 YoY increase over the previous financial year. Operating profits were Rs. 1.4 billion, 54.4 per cent YoY growth, whilst earnings grew at 32.9 per cent to stand at Rs. 1.1 billion. Excluding the one-off capital gains recorded previous year, underlying earnings growth was 49.3 per cent.  ”This performance has been driven by our Bangladesh operation maintaining excellent revenue and profit growth, strong sales across all our major brands in the domestic market and relatively weak commodity prices for key raw material inputs” the release said adding the healthcare sector revenue for the nine months under review stood at Rs. 11.9 billion, a YoY increase of 18.3 per cent whilst earning grew at 25.8 per cent.”

During December Hemas’ newest hotel property, Anantara Peace Haven Tangalle Resort was opened. “The leisure segment recorded total revenue of Rs. 2.2 billion reflecting a 9.2 per cent YoY growth for the nine months,” the release said. Hospitals growth in revenue contributed 31 per cent of the overall segments revenue growth. Hemas pharmaceutical distribution operation registered a YoY topline growth of 12.1 per cent maintaining its market leadership position, according to the release. The pharmaceutical sales growth continues to be driven by our strong presence in growing segments, the release said.

Advertising Rates

Please contact the advertising office on 011 - 2479521 for the advertising rates.